USPTO Patent Grant: Therapeutic Lasers for Ophthalmology

The United States Patent and Trademark Office (USPTO) has granted patent US12582553B2, titled 'Spatial light modulation targeting of therapeutic lasers for treatment of ophthalmological conditions,' to Pulsemedica Corp. The patent describes a therapeutic laser system that utilizes spatial light modulation to focus the laser beam on multiple target locations simultaneously, intended for treating eye conditions. The patent was filed on April 26, 2024, and is assigned to Pulsemedica Corp. with inventors Nir Katchinskiy and Abdulhakem Elezzabi.

This patent grant represents a new intellectual property asset in the field of ophthalmic therapeutic lasers. While not a regulatory rule or enforcement action, it signifies innovation that may influence future product development and market competition in the medical device sector. Companies operating in ophthalmology and therapeutic laser technology should be aware of this granted patent as it may impact their freedom to operate or present licensing opportunities. No immediate compliance actions are required for regulated entities based solely on this patent grant.